Autoimmune hepatitis in patients with human immunodeficiency virus infection: A systematic review of the published literature.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
14
9
2019
pubmed:
14
9
2019
medline:
26
9
2019
Statut:
ppublish
Résumé
Liver disease in patients with HIV is common and typically has complex and multifactorial presentations that represent a major cause of morbidity and mortality. Autoimmune hepatitis (AIH) is rarely reported in patient with HIV and the disease course and clinical outcomes for treatment have not been well characterized. We are aiming to determine the patient characteristics, disease prevalence, and treatment outcomes from published articles of patients with HIV and AIH. A systematic search of PubMed, Web of Science, and Google Scholar through February 20, 2019 identified 15 studies that reported the outcomes of AIH in patients with HIV. Because of the small sample sizes and skewed distributions, resampling tests of mean differences using permutation distributions (MAXn = 10,000 permutations) were utilized; analyses were performed using R (v. 3.5.1). Categorical differences were calculated using Fisher exact test for odds ratio = 1 (equal odds), and Cramer V was calculated for effect size; analyses were completed in SPSS (v. 25). By reviewing 15 studies reporting a total of 35 patients with AIH and HIV, male patients were found to have significantly higher aspartate transaminase and alanine transaminase levels at time of diagnosis. No other significant findings identified. The CD4 count and viral load did not show significant correlation with AIH diagnosis or its prognosis. All patients but one who presented with severe immune deficiency and responded to highly active anti-retroviral therapy received immunosuppressive treatment without side effects and achieved remission except 2 lost to follow-up and 3 expired. Although rare, but AIH can develop in patients with HIV and physicians should consider it in the differential diagnosis for HIV patients presented with abnormal liver function tests, especially after excluding hepatitis C virus and drug-induced liver injury.Patients with immune deficiency disorders who present with AIH can be treated safely with steroid either as monotherapy or in combination with another immune suppressant therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Liver disease in patients with HIV is common and typically has complex and multifactorial presentations that represent a major cause of morbidity and mortality. Autoimmune hepatitis (AIH) is rarely reported in patient with HIV and the disease course and clinical outcomes for treatment have not been well characterized. We are aiming to determine the patient characteristics, disease prevalence, and treatment outcomes from published articles of patients with HIV and AIH.
METHOD
METHODS
A systematic search of PubMed, Web of Science, and Google Scholar through February 20, 2019 identified 15 studies that reported the outcomes of AIH in patients with HIV. Because of the small sample sizes and skewed distributions, resampling tests of mean differences using permutation distributions (MAXn = 10,000 permutations) were utilized; analyses were performed using R (v. 3.5.1). Categorical differences were calculated using Fisher exact test for odds ratio = 1 (equal odds), and Cramer V was calculated for effect size; analyses were completed in SPSS (v. 25).
RESULTS
RESULTS
By reviewing 15 studies reporting a total of 35 patients with AIH and HIV, male patients were found to have significantly higher aspartate transaminase and alanine transaminase levels at time of diagnosis. No other significant findings identified. The CD4 count and viral load did not show significant correlation with AIH diagnosis or its prognosis. All patients but one who presented with severe immune deficiency and responded to highly active anti-retroviral therapy received immunosuppressive treatment without side effects and achieved remission except 2 lost to follow-up and 3 expired.
CONCLUSION
CONCLUSIONS
Although rare, but AIH can develop in patients with HIV and physicians should consider it in the differential diagnosis for HIV patients presented with abnormal liver function tests, especially after excluding hepatitis C virus and drug-induced liver injury.Patients with immune deficiency disorders who present with AIH can be treated safely with steroid either as monotherapy or in combination with another immune suppressant therapy.
Identifiants
pubmed: 31517833
doi: 10.1097/MD.0000000000017094
pii: 00005792-201909130-00024
pmc: PMC6750342
doi:
Substances chimiques
Immunosuppressive Agents
0
Aspartate Aminotransferases
EC 2.6.1.1
Alanine Transaminase
EC 2.6.1.2
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e17094Références
Kia L, Beattie A, Green RM. Autoimmune hepatitis in patient with HIV, A case reports of rare but important diagnosis with therapeutic implications. Medicine 2017;96:7 (e6011).
Zoboli F, Ripamonti D, Benatti SV, et al. Autoimmune hepatitis and HIV: two case reports and literature review. AIDS 2017;31:2172DOI: 10.1097/QAD.0000000000001608.
doi: 10.1097/qad.0000000000001608
Parekh S, Spiritos Z, Reynolds P, et al. HIV and autoimmune hepatitis: a case series and literature review. J Biomedical Sci 2017;6:2.
Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193.
German V, Vassiloyanakopoulos A, Sampaziotis D, et al. Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy. Scand J Infect Diseases 2005;37:148–51.
Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 2008;43:1232.
Wang Q, Yang F, Miao Q, et al. The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J Autoimmun 2016;66:98.
Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54.
Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009;50:1210.
Morbidity and mortality weekly report (MMWR) by CDC June 01, 2001/50(21);430-4.
Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009;9:235–45.
Shirai A, Cosentino M, Leitman-Klinman K, et al. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 1992;89:561–6. doi: 10.1172/JCI115621.
doi: 10.1172/jci115621
Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:92938.
Abe M, Onji M, Kawai-Ninomiya K, et al. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 2007;5:255.
Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517.
Fernandez-Sanchez M, Iglesias MC, Ablanedo-Terrazas Y, et al. Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection. AIDS 2016;30:909–14.
Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol 2010;8:1002–12.
Price JC, Thio CL. Liver disease in HIV infected individual. Clin Gastroenterol Hepatol 2010;8:1002–12.
Puius YA, Dove LM, Brust DG, et al. Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol 2008;42:425–9.
Vispo E, Maida I, Moreno A, et al. Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. J Antimicrob Chemother 2008;62:1470–2.
Caplan M. Primary biliary cirrhosis overlapping with autoimmune hepatitis in an HIV-infected patient on antiretroviral therapy. J Interdiscip Histopathol 2013;1:270–3.
o’leary J. De Novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis 2008;46:e12–4. doi: 10.1086/524082.
doi: 10.1086/524082
Roszkiewicz J, smolewska E. Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int 2016;36:1481–91.
Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329–37.
O’Leary JG, Zachary K, Misdraji J, et al. De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis 2008;46:e12–4.
Daas H, Khatib R, Nasser H. Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature. J Med Case Rep 2011;5:233.
Murunga E, Andersson M, Rensburg CV, et al. Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients? Scand J Gastroenterol 2016;51:814–8.
Cazanave C, Rakotondravelo S, Morlat P, et al. Autoimmune hepatitis in a HIV–HCV co-infected patient: diagnostic and therapeutic difficulties. Rev Méd Interne 2006;27:414–9.
Wan DW, Marks K, Yantiss RK, et al. Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma. AIDS Patient Care STDS 2009;23:407–13.
Ofori E, Ramai D, Ona MA, et al. Autoimmune hepatitis in the setting of human immunodeficiency virus infection: A case series. World J Hepatol 2017;9:1367–71.
Hagel S, Bruns T, Herrmann A, et al. Autoimmune hepatitis in an HIV-infected patient: an intriguing association. Int J STD AIDS 2012;23:448–50.
Coriat R, Podevin P. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int J STD AIDS 2008;19:208–10.